These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22664242)

  • 1. Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.
    Tateishi U; Oka T; Inoue T
    Curr Med Chem; 2012; 19(20):3301-9. PubMed ID: 22664242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
    Liu S
    Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
    Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
    Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
    Liu Z; Liu S; Wang F; Liu S; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1296-307. PubMed ID: 19296102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD-based PET tracers for imaging receptor integrin αv β3 expression.
    Cai H; Conti PS
    J Labelled Comp Radiopharm; 2013 May; 56(5):264-79. PubMed ID: 24285371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
    Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).
    Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M
    Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.
    Liu S
    Bioconjug Chem; 2009 Dec; 20(12):2199-213. PubMed ID: 19719118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
    Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
    J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.
    Chen H; Niu G; Wu H; Chen X
    Theranostics; 2016; 6(1):78-92. PubMed ID: 26722375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.
    Beer AJ; Haubner R; Sarbia M; Goebel M; Luderschmidt S; Grosu AL; Schnell O; Niemeyer M; Kessler H; Wester HJ; Weber WA; Schwaiger M
    Clin Cancer Res; 2006 Jul; 12(13):3942-9. PubMed ID: 16818691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.
    Knetsch PA; Petrik M; Rangger C; Seidel G; Pietzsch HJ; Virgolini I; Decristoforo C; Haubner R
    Nucl Med Biol; 2013 Jan; 40(1):65-72. PubMed ID: 23102540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
    Su ZF; Liu G; Gupta S; Zhu Z; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2002; 13(3):561-70. PubMed ID: 12009947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Characterization of 4
    Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
    J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concise review of current radiopharmaceuticals in tumor angiogenesis imaging.
    Lu X; Wang RF
    Curr Pharm Des; 2012; 18(8):1032-40. PubMed ID: 22272823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
    Haubner R; Wester HJ; Burkhart F; Senekowitsch-Schmidtke R; Weber W; Goodman SL; Kessler H; Schwaiger M
    J Nucl Med; 2001 Feb; 42(2):326-36. PubMed ID: 11216533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation.
    Wu H; Jiang J; Xu H; Li Q; Cai J
    Expert Opin Ther Pat; 2016; 26(1):131-7. PubMed ID: 26560186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.